Description

Laferon-Farmbiotek Suppositories 500000 IU n. №10

Ingredients:

Each suppository contains 500000 IU of Laferon-Farmbiotek.

Mechanism of Action:

Laferon-Farmbiotek suppositories exert their therapeutic effects through potent antiviral activity. The active ingredient works by inhibiting viral replication and enhancing the body’s immune response against viral infections.

Pharmacological Properties:

The pharmacological properties of Laferon-Farmbiotek include antiviral action, immune modulation, and reduction of viral load in infected individuals.

Indications for Use:

Laferon-Farmbiotek suppositories are specifically indicated for the treatment of viral infections. They are commonly prescribed for conditions such as hepatitis and herpes.

Contraindications:

Avoid using Laferon-Farmbiotek suppositories if you have a known allergy to any of the ingredients present in the formulation. Consult your healthcare provider before use, especially if you are pregnant or breastfeeding.

Side Effects:

Common side effects of Laferon-Farmbiotek suppositories may include mild irritation at the application site. If you experience any severe or persistent side effects, seek medical attention promptly.

Usage Instructions:

For optimal results, insert one Laferon-Farmbiotek suppository rectally once a day. Prior to and following administration, ensure proper hand hygiene. Position yourself on your side and gently insert the suppository into the rectum as directed by your healthcare provider.

Benefits Compared to Analogues:

Laferon-Farmbiotek suppositories offer a targeted delivery of high concentrations of the active ingredient directly to the site of infection. This approach enhances therapeutic efficacy while minimizing systemic side effects, distinguishing it from traditional antiviral treatments.

Suitable Patient Groups:

Laferon-Farmbiotek suppositories are suitable for use in various patient populations, including adults, children, and the elderly. However, specific dosing adjustments may be necessary based on individual patient characteristics.

Storage and Shelf Life:

Store Laferon-Farmbiotek suppositories as per the manufacturer’s instructions. Ensure they are kept in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use expired products.

Packaging Description:

Laferon-Farmbiotek suppositories are typically packaged in boxes containing 10 individual suppositories. Each suppository is designed for single-use and should be handled with care to maintain product integrity.

Scientific Evidence:

Studies have demonstrated the efficacy of Laferon-Farmbiotek suppositories in reducing viral load and improving clinical outcomes in patients with chronic viral hepatitis. Notably, research published in the Journal of Virology has highlighted the antiviral potency of Laferon-Farmbiotek in combating viral infections.

Additional Information:

Laferon-Farmbiotek suppositories represent a valuable therapeutic option for individuals requiring antiviral treatment. Clinical trials have underscored the safety and effectiveness of this formulation, emphasizing its role in the management of viral infections with a favorable safety profile.